前收市價 | 12.55 |
開市 | 12.15 |
買盤 | 10.10 |
賣出價 | 14.60 |
拍板 | 37.50 |
到期日 | 2024-09-20 |
今日波幅 | 12.15 - 12.55 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 無 |
French drugmaker Sanofi is poised to commit between 1.3 billion euros and 1.5 billion euros ($1.4 billion – $1.6 billion) to enhancing its insulin production site in Frankfurt, Germany. The site in Frankfurt’s Hoechst district is known for producing the company’s insulin brand, Lantus. Also Read: Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M. This move comes after initial plans to shift Lantus production to France were reconsidered. The de
(Bloomberg) -- US scientists haven’t gotten a handle on how to effectively track bird flu, three months after a Texas dairy worker was diagnosed with the virus. That’s impeding the ability to create a vaccine to protect against the spread among people.Most Read from BloombergDemocrats Weigh Mid-July Vote to Formally Tap Biden as NomineeTrump Immunity Ruling Means Any Trial Before Election UnlikelyBlackRock Buys Preqin for $3.2 Billion in Private Data PushTrump as President or Private Citizen: Wh
We recently published a list of the 10 Stocks to Buy and Sell Before the Third Quarter 2024 According to Jim Cramer. Since Novavax Inc (NASDAQ:NVAX) ranks 10th on the list, it deserves a deeper look. Jim Cramer in a latest program discussed the changing consumer trends in the US, wondering whether the consumer is just […]